Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase

British Journal of Pharmacology

Volumn 136, Issue 5, 2002, Pages 693-700

  Cashen, Doreen E ^a   MacIntyre, D Euan ^a   Martin, William J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cavernous nerve; Electrical stimulation; Erectile function; Nitric oxide synthase; Phosphodiesterase inhibitors; Sildenafil

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SILDENAFIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, MOUSE; NOS3 PROTEIN, MOUSE; PIPERAZINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; ELECTRIC POTENTIAL; ELECTROSTIMULATION; FACILITATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DRUG ANTAGONISM; ENZYMOLOGY; IMPOTENCE; METABOLISM; METHODOLOGY; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PRESSURE; ELECTRIC STIMULATION; IMPOTENCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PENILE ERECTION; PIPERAZINES; SIGNAL TRANSDUCTION;

EID: 0035987777     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704772     Document Type: Article

References (27)

1. Pharmacology of penile erection
2. Physiology of penile erection
3. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
4. Role of nitric oxide in the physiology of erection
5. Lecture 2: Nitric oxide synthase and heme oxygenase knockout mice - What have we learned?
6. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase
7. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis
8. Erectile dysfunction
9. Neural control of penile erection in the rat
10. Oral sildenafil in the treatment of erectile dysfunction
11. Expression of penile neuronal nitric oxide synthase variants in the rat and mouse penile nerves
12. Nitric oxide and the cyclic GMP system in the penis
13. Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice
14. Targeted disruption of the neuronal nitric oxide synthase gene
15. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
16. Nitric oxide as the physiological mediator of penile erection
17. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
18. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor
19. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-)
20. Erectile dysfunction
21. Cyclic guanosine monophosphate mediates penile erection in the rat
22. Morphological and functional in vitro and in vivo characterization of the mouse corpus cavernosum
23. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction
24. Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction
25. Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells
26. Intracavernosal pressure monitoring in mice: Responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration
27. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose